Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NALOXEGOL OXALATE (PREMIX), with a corresponding US DMF Number 32562.
Remarkably, this DMF maintains an Active status since its submission on March 21, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 16, 2018, and payment made on April 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II